# FDA Inspection 1162086 - Reproductive Care Center - February 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/reproductive-care-center/6422bdbb-e4db-4ad6-bc18-ebfca3233a7b
Source feed: FDA_Inspections

> FDA Inspection 1162086 for Reproductive Care Center on February 11, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162086
- Company Name: Reproductive Care Center
- Inspection Date: 2022-02-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269605 - 2025-05-14](https://www.keypedia.com/records/fda_inspections/reproductive-care-center/b7a8667c-6745-4472-bc44-192214f4d263)
- [FDA Inspection 1162086 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/reproductive-care-center/d3548cad-9969-485b-a86c-3d4c700cd73e)
- [FDA Inspection 1162086 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/reproductive-care-center/4f8ad9ca-5ac0-4499-afd2-d70b1fbda9b2)
- [FDA Inspection 1001142 - 2017-02-15](https://www.keypedia.com/records/fda_inspections/reproductive-care-center/4968d46d-2c2a-48bc-8764-eaa08014297b)
- [FDA Inspection 1001142 - 2017-02-15](https://www.keypedia.com/records/fda_inspections/reproductive-care-center/bdc7b52e-40ae-48e1-baf5-ac83290be4a9)

Company: https://www.keypedia.com/companies/reproductive-care-center/5c1374d4-9258-4ea2-814a-1184ae36b2e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d